Market access in healthcare refers to the processes and strategies employed to ensure that patients have timely and affordable access to medical products, treatments, and services that meet their healthcare needs.
Health economics is a branch of economics concerned with the efficient allocation of healthcare resources and the impact of healthcare policies and interventions on individuals and populations.
HTA is a multidisciplinary process that evaluates the clinical effectiveness, cost-effectiveness, and broader impact of healthcare technologies, including drugs, medical devices, and procedures, to inform healthcare decision-making.
Pricing and reimbursement refer to the mechanisms by which healthcare payers, such as governments, insurers, and healthcare providers, determine the price they are willing to pay for healthcare products and services and how those costs are reimbursed.
The value proposition in healthcare refers to the unique benefits and value that a healthcare product or service offers to patients, healthcare providers, payers, and other stakeholders compared to alternative options.
A market access strategy outlines the approach and tactics employed by pharmaceutical companies, medical device manufacturers, and other healthcare stakeholders to navigate regulatory, reimbursement, and market barriers and optimize access to healthcare products and services.
Patient access programs are initiatives developed by pharmaceutical companies and other healthcare organizations to improve patient access to essential medicines and treatments, often through financial assistance, patient support services, and education.
Healthcare policy encompasses the laws, regulations, and guidelines established by governments and other authorities to govern the provision, financing, and delivery of healthcare services, including policies related to market access, reimbursement, and quality assurance.
Healthcare stakeholders include patients, healthcare providers, payers, policymakers, industry associations, advocacy groups, and other entities with an interest in or influence on healthcare policy, delivery, and outcomes.
Market access challenges in healthcare include regulatory hurdles, pricing pressures, reimbursement restrictions, limited patient access, healthcare disparities, and other barriers that impede the availability, affordability, and equitable distribution of healthcare products and services.